PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Timex Contract Win

14 Jun 2006 07:00

Embargoed Release: 07:00hrs Wednesday 14th June 2006 Sopheon Plc (`Sopheon') Timex Advances Innovation Strategy with Sopheon's Accolade System Leading Watchmaker Up and Running with Best-Practice Product Innovation Process in Only 60 Days Sopheon, the international software and services company, is pleased toannounce that Timex Corporation, the largest-selling wristwatch brand inAmerica, has deployed Sopheon's Accolade as its product innovation process andproduct portfolio management solution. Timex recently completed enterprise-wideimplementation of the system across all departments and to executive managementin a rollout that took approximately 60 days.Connecticut-based Timex was founded in 1854. It sells more than 30 millionwatches annually. The privately held company employs 7500 people at facilitieslocated in the U.S., South America, Europe and Asia.Timex operates in a fiercely competitive industry where ever-shorter productlife cycles have made continuous technology innovation critical to marketsuccess. Faced with the emergence of alternative timekeeping devices such ascell phones, PDAs and computers, Timex has continued to innovate and evolve itscore lines while expanding its product portfolio to include multi-functionwrist pagers, compasses, heart monitors and thermometers.Timex's implementation of Sopheon's Accolade system is integral to thecompany's adoption of Stage-Gate, the widely used product developmentmethodology. Accolade is being used to automate the Stage-Gate process and toprovide decision-making support for management of the company's increasinglycomplex portfolio of products. A primary reason Timex selected the Sopheonsolution is that it is specifically designed to support stage- or phase-basedproduct development processes and has proven capacity to strengthen processgovernance and throughput. Other considerations included the software'sease-of-use, its simple configurability and the speed with which it can beimplemented"We set a very aggressive timetable for our rollout of Accolade," said BerndBecker, vice president of product development at Timex. "Given the complexityof the implementation and the level of configuration required, I never expectedthat Sopheon would finish on time. But they did-in just two months and with nostart-up issues. Some of the first reactions to Accolade came from seniormanagement. They were immediately impressed by the level of detailedinformation the system gave them, and the ease with which that informationcould be accessed. With Accolade in place across our organization, we are doinga better job of managing our R&D investments, and we are fully realizing thebenefits of Stage-Gate. Sopheon and Accolade were clearly the right choice.""Most of the companies we deal with have identified innovation as a topstrategic priority and are acting with urgency," said Andy Michuda, chiefexecutive officer of Sopheon. "We give our clients the advantage of a systemthat is easy to implement, and customer service support that emphasizes workingsmart and fast without a lot of involvement by internal IT to deliver asolution that maps precisely to the adopting organization's requirements. Timexhad a clearly defined process and was very savvy about what they wanted toaccomplish through our software. As a result, we were able to hit the groundrunning and, working closely with their team, put a fully automated,world-class innovation system in place in a matter of weeks. For the client,this translates into accelerated time-to-value and a sustainable source ofimportant competitive advantage."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Timex is a registered trademark of the Timex Corporation.Stage-Gate is a registered trademark of the Product Development Institute.All other trademarks and registered trademarks are the soleproperty of their respective owners.About TimexFounded in 1854, Timex is a privately owned company with manufacturing plantsand company offices in over 80 countries around the world. With more thanone-billion watches bearing the Timex brand sold world-wide, the TimexCorporation has been providing innovative, well-designed, and reliabletimepieces for over 150 years. For more information, please visit www.timex.comAbout SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 754 010ENDSOPHEON PLC
Date   Source Headline
10th Jun 20217:00 amRNSAGM Statement
3rd Jun 20211:50 pmRNSIssue of Equity
2nd Jun 20217:00 amRNSSopheon Deployed Globally at The 3M Company
14th May 202110:11 amRNSGrant of Options / PDMR dealing
14th Apr 20217:00 amRNSLaunch of Accolade for Smart Products
9th Apr 20214:15 pmRNSIssue of Equity
31st Mar 20217:00 amRNSDirectorate Change
29th Mar 20212:30 pmRNSDirector Shareholdings
24th Mar 20217:00 amRNSFinal Results
3rd Mar 202111:02 amRNSHolding(s) in Company
2nd Mar 202112:12 pmRNSHolding(s) in Company
26th Feb 20214:20 pmRNSResult of Secondary Placing
26th Feb 20211:36 pmRNSProposed Secondary Placing
8th Feb 20214:30 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSSopheon extend innovation leadership with Simplot
25th Jan 20217:00 amRNSTrading Update
5th Nov 20207:00 amRNSRelease of Accolade version 13.2
12th Oct 20207:00 amRNSSeasoned Cloud & Industry Executive added to Team
9th Sep 20209:55 amRNSOrion Engineered Carbons works with Sopheon
1st Sep 202011:38 amRNSDirector Shareholdings
28th Aug 202012:39 pmRNSIssue of Equity
27th Aug 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSMondelez Partnership
13th Jul 202011:41 amRNSGrant of Options/PDMR Dealing
11th Jun 202011:28 amRNSResult of AGM
9th Jun 202012:00 pmRNSIssue of Equity & Director/PDMR Shareholding
28th May 20207:29 amRNSProgressive publishes new research
28th May 20207:00 amRNSNew Sopheon Release Integrating Microsoft Teams
15th May 202010:01 amRNSIssue of Equity
15th May 20207:00 amRNSAGM Notice and Update
3rd Apr 202011:17 amRNSDirector Shareholdings
25th Mar 20201:38 pmRNSIssue of Equity
19th Mar 20204:46 pmRNSIssue of Equity
19th Mar 20207:00 amRNSFinal Results
28th Jan 20209:05 amRNSSecond Price Monitoring Extn
28th Jan 20209:00 amRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSTrading Update
10th Jan 20201:00 pmRNSIssue of Equity
11th Dec 20197:00 amRNSTrading Update
10th Oct 201912:00 pmRNSIssue of Equity
1st Oct 201912:00 pmRNSIssue of Equity
20th Sep 20194:45 pmRNSIssue of Equity
22nd Aug 20192:06 pmRNSSecond Price Monitoring Extn
22nd Aug 20192:01 pmRNSPrice Monitoring Extension
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
22nd Aug 20199:05 amRNSSecond Price Monitoring Extn
22nd Aug 20199:00 amRNSPrice Monitoring Extension
22nd Aug 20197:00 amRNSHalf-year Report
12th Aug 201910:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.